Followers | 182 |
Posts | 42817 |
Boards Moderated | 2 |
Alias Born | 05/02/2008 |
Wednesday, April 06, 2022 3:15:53 PM
Recent LGVN News
- Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 05/02/2024 12:03:00 PM
- Longeveron to Present at the Planet MicroCap Showcase • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC) • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Longeveron Announces Closing of $5.2 Million Public Offering • GlobeNewswire Inc. • 04/11/2024 09:17:27 PM
- Longeveron Announces Pricing of $5.25 Million Public Offering • GlobeNewswire Inc. • 04/08/2024 06:15:00 PM
- Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals • GlobeNewswire Inc. • 04/08/2024 12:30:00 PM
- IBN Announces Latest Episode of The Bell2Bell Podcast featuring Wa’el Hashad, CEO of Longeveron Inc. • GlobeNewswire Inc. • 11/14/2023 01:17:00 PM
- IBN Coverage Initiated for Longeveron Inc. • GlobeNewswire Inc. • 09/07/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:34:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 09:27:03 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 08/16/2023 05:21:55 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 08/14/2023 08:55:05 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/14/2023 08:45:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:30:11 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/11/2023 08:31:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:58:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 09:00:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 09:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 09:00:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM